+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

Why Pfizer's not worried about resistance to its new antiviral

Nov 8, 2021, 20:13 IST
Business Insider
Mikael Dolsten, Pfizer's chief scientific officer Pfizer

Hello,

Advertisement

Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lrosenbaum@insider.com or tweet @leah_rosenbaum. Let's get to it...

Resistance is one of the biggest threats to new COVID-19 treatments. Here's why Pfizer's top scientist, Mikael Dolsten, isn't worried it will weaken the pharma giant's new pill.

Check it out>>

A customer scans her phone as she enters Amazon's new Amazon Fresh store in Ealing, west London, on March 4, 2021. NIKLAS HALLE'N/AFP via Getty Images
Amazon considers offering prescription drugs and lottery tickets in its cashierless grocery stores to boost traffic

See the exclusive now>>

Advertisement

Benjamin Hayes, age 5, at Children's National Hospital in Washington, DC. Children’s National Hospital
See some of the first 5- to 11-year-old kids get their COVID-19 vaccines

Read more>>

More stories we're reading:

-Leah

You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article